only search Keymodule website

SPROUT User Presentations

Novel inhibitors of isoleucyl-tRNA synthetase as potential antibacterial drugs
Nicola J. Potter, Ian Chopra, Julian G. Hurdle, A. Peter Johnson, Colin W.G. Fishwick
School of Chemistry, and Institute of Molecular and Cellular Biology
University of Leeds, Leeds, LS2 9JT, UK
5th Joint Meeting on Medicinal Chemistry
June 2007
Portoroz, Slovenia
Structure-based design of inhibitors of dihydroorotate dehydrogenases
Timo Heikkila, Matthew Davies, Mark R. Parsons, A. Peter Johnson
School of Chemistry, and the Astbury Centre for Structural Molecular Biology
University of Leeds, Leeds, LS2 9JT, UK
Design and synthesis of new dihydroorotate dehydrogenase inhibitors as potent antimalarials
Matthew Davies, Timo Heikkila, Colin W. G. Fishwick, A. Peter Johnson
School of Chemistry, and School of Biochemistry and Microbiology
University of Leeds, Leeds, LS2 9JT, UK
De novo design and synthesis of novel RNA polymerase inhibitors as potential anti-tuberculosis agents
Anil K. Agarwal, Julian Hurdle, Amer I. AlOmar, Ian Chopra, A. Peter Johnson, Colin W. G. Fishwick
School of Chemistry, and School of Biochemistry and Microbiology
University of Leeds, Leeds, LS2 9JT, UK
Three for three: De novo design of multiple novel chemotypes of T-type calcium channel blockers
Daniel L. Cheney, Jon J. Hangeland, Todd J. Friends, Paul C. Levesque
Computer-Assisted Drug Design
Cardiovascular Discovery Chemistry, and Cardiovascular Diseases
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ
229th ACS National Meeting, COMP 148
March 2005
San Diego, CA
De novo design of novel and selective T-type calcium channel blockers
Daniel L. Cheney, Jon J. Hangeland, Todd J. Friends, Paul C. Levesque
Computer-Assisted Drug Design
Cardiovascular Discovery Chemistry, and Cardiovascular Diseases
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ
229th ACS National Meeting, COMP 314
March 2005
San Diego, CA
Design, synthesis and SAR of novel and selective T-type calcium channel antagonists containing a biaryl sulfonamide core
Jon J. Hangeland, Todd J. Friends, Daniel L. Cheney, Paul C. Levesque, Adam J. Rich, Lucy Sun, Terry R. Bridal, Leonard P. Adam, Diane E. Normandin
Cardiovascular Discovery Chemistry
Department of Macromolecular Structure, and Cardiovascular Diseases
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ
229th ACS National Meeting, MEDI 105
March 2005
San Diego, CA